Federal Register / Vol. 60, No. 36 / Thursday, February 23, 1995 / Notices 10085

National Courier Ass’n v. Board of

Governors, 516 F.2d 1229, 1237 (D.C.

Cir. 1975). In addition, the Board may

consider any other basis that may

demonstrate that the activity has a

reasonable or close relationship to

banking or managing or controlling

banks. Board Statement Regarding

Regulation Y, 49 FR 806 (1984).

The Board has previously approved,

by regulation, providing investment and

financial advisory services, 12 CFR

225.25(b)(4)(i)-(v) and (vi)(A)(1) and (2),

providing investment advice to nonaffiliated persons with respect to the

purchase and sale of financial futures

contracts and options on such futures

contracts, 12 CFR 225.25(b)(19) and

trust services, 12 CFR 225.25(b)(3).

Applicant has stated that it would

conduct these proposed activities

subject to the requirements and

limitations of the Board’s Regulation Y.

The Board also has previously

determined by order that the provision

of investment advisory services with

respect to financial futures and options

on futures contracts on bonds, interest

rates and stock and bond indexes is a

permissible activity pursuant to Section

4(c)(8) of the BHC Act. See SR 93-27;

National Westminster Bank PLC, 78

Federal Reserve Bulletin 953 (1992);

Manufacturers Hanover Corporation, 76

Federal Reserve Bulletin 774 (1990); and

The HongKong and Shanghai Banking

Corporation, 76 Federal Reserve

Bulletin 770 (1990). The Board has also

approved the providing of investment

advice through limited partnerships.

See Meridian Bancorporation, 80

Federal Reserve Bulletin 736 (1994).

Applicant proposes to comply with

commitments similar to those relied on

by the Board in Meridian, but seeks, in

the alternative, a determination that

Brinson Partners does not control the

limited partnerships for purposes of the

Bank Holding Company Act, or, if it is

deemed to control the partnerships,

‘‘grandfather’’ treatment for four existing

limited partnerships that Brinson

Partners serves as general partner.

In order to satisfy the proper incident

to banking test, section 4(c)(8) of the

BHC Act requires the Board to find that

the performance of the activities by

Company can reasonably be expected to

produce benefits to the public, such as

greater convenience, increased

competition, or gains in efficiency that

outweigh possible adverse effects, such

as undue concentration of resources,

decreased or unfair competition,

conflicts of interest, or unsound banking

practices. Applicant believes that the

proposed activities will benefit the

public by providing access by customers

of Applicant to the institutional asset

management experience and expertise

of Brinson Partners and by permitting

Applicant to draw on such experience

and expertise to enhance its investment

advisory products and services.

Applicant believes that competition will

be fostered by enhancing the ability of

Applicant to compete in the asset

management arena with sophisticated

competitors as a result of the

combination of Applicant’s existing

institutional asset management business

with that of Brinson Partners and

Brinson Trust. Applicant further

believes that the proposal will not result

in adverse effects.

In publishing the proposal for

comment, the Board does not take a

position on issues raised by the

proposal. Notice of the proposal is

published solely in order to seek the

views of interested persons on the

issues presented by the application and

does not represent a determination by

the Board that the proposal meets, or is

likely to meet, the standards of the BHC

Act.

Any comments or requests for hearing

should be submitted in writing and

received by William W. Wiles,

Secretary, Board of Governors of the

Federal Reserve System, Washington,

D.C. 20551, not later than March 8,

1995. Any request for a hearing on this

application must, as required by §

262.3(e) of the Board’s Rules of

Procedure (12 CFR 262.3(e)), be

accompanied by a statement of the

reasons why a written presentation

would not suffice in lieu of a hearing,

identifying specifically any questions of

fact that are in dispute, summarizing the

evidence that would be presented at a

hearing, and indicating how the party

commenting would be aggrieved by

approval of the proposal.

This application may be inspected at

the offices of the Board of Governors or

the Federal Reserve Bank of New York.

Board of Governors of the Federal Reserve

System, February 16, 1995.

William W. Wiles,

Secretary of the Board.

[FR Doc. 95-4348 Filed 2-22-95; 8:45 am]

BILLING CODE 6210-01-F

FEDERAL TRADE COMMISSION

Granting of Request for Early

Termination of the Waiting Period

Under the Premerger Notification

Rules

Section 7A of the Clayton Act, 15

U.S.C. 18a, as added by Title II of the

Hart-Scott-Rodino Antitrust

Improvements Act of 1976, requires

persons contemplating certain mergers

or acquisitions to give the Federal Trade

Commission and the Assistant Attorney

General advance notice and to wait

designated periods before

consummation of such plans. Section

7A(b)(2) of the Act permits the agencies,

in individual cases, to terminate this

waiting period prior to its expiration

and requires that notice of this action be

published in the Federal Register.

The following transactions were

granted early termination of the waiting

period provided by law and the

premerger notification rules. The grants

were made by the Federal Trade

Commission and the Assistant Attorney

General for the Antitrust Division of the

Department of Justice. Neither agency

intends to take any action with respect

to these proposed acquisitions during

the applicable waiting period.

TRANSACTIONS GRANTED EARLY TERMINATION BETWEEN: 013095 AND 021095

Name of acquiring person, name of acquired person, name of acquired entity PMN No. Date terminated

The Foothill Group, Inc., Norfolk Shipbuilding & Drydock Corporation, Flagship Financial Corporation ................... 95–0835 01/30/95

Cilluffo Associates, L.P., Stone & Webster, Incorporated, Stone & Webster, Incorporated, ..................................... 95–0795 01/31/95

Cilluffo Associates, L.P., GRC International, Inc., GRC International, Inc. ................................................................ 95–0796 01/31/95

AT&T Corp., GFC Financial Corporation Greyhound Financial Corporation .............................................................. 95–0881 01/31/95

BASF Aktiengesellschaft, The Boots Company, The Boots Company (USA) Inc. .................................................... 95–0830 02/01/95

Value Health, Inc., Group Hospitalization and Medical Services, Inc., Health Management Strategies International, Inc. ............................................................................................................................................................ 95–0832 02/01/95

Sears, Roebuck and Co., Federated Department Stories, Inc., Stern’s Department Stores, Inc. ............................. 95–0834 02/01/95

E. I. DuPont de Nemours and Company, Amoco Corporation, Amoco Production Company .................................. 95–0859 02/01/95

Amoco Corporation, E. I. DuPont de Nemours and Company, Conoco, Inc. ............................................................ 95–0860 02/01/95

Kidd, Kamm Equity Partners, L.P., Irving and Audrey Gronsky, Bristol Foods, Inc. .................................................. 95–0896 02/01/95
10086 Federal Register / Vol. 60, No. 36 / Thursday, February 23, 1995 / Notices

TRANSACTIONS GRANTED EARLY TERMINATION BETWEEN: 013095 AND 021095—Continued

Name of acquiring person, name of acquired person, name of acquired entity PMN No. Date terminated

Harbour Group Investments III, L.P., DelCorp Incorporated, DelCorp Incorporated .................................................. 95–0901 02/01/95

Penn Virginia Corporation, United Meridian Corporation, UMC Petroleum Corporation ............................................ 95–0903 02/01/95

Philipp Holzmann, A.G., Costain Group PLC, The Dolet Hills Mining Venture .......................................................... 95–0905 02/01/95

North Shore Regional, Health System, Huntington Hospital, Huntington Hospital .................................................... 95–0822 02/03/95

Archer-Daniels-Midland Company, Archer-Daniels—Midland Company, Independent Soy Processors Company .. 95–0895 02/03/95

USF&G Corporation, Victoria Financial Corporation, Victoria Financial Corporation ................................................. 95–0897 02/03/95

La-Z Boy Chair Company, England/Corsair, Inc., England/Corsair, Inc. .................................................................... 95–0912 02/03/95

Siemens Aktiengesellschaft, Pyramid Technology Corporation, Pyramid Technology Corporation .......................... 95–0913 02/03/95

Corporate Express, Inc., G. Lynn Shostack, Joyce International, Inc. ....................................................................... 95–0926 02/03/95

HBE Corporation, Barclays PLC, Pawnee-Daytona Inc. ............................................................................................ 95–0965 02/03/95

Logicon, Inc., Harnischfeger Industries, Inc., Syscon Corporation ............................................................................. 95–0920 02/06/95

Corning Incorporated, Corning BioPro Inc., Corning BioPro Inc ................................................................................ 95–0928 02/06/95

United Healthcare Corporation, Luis A. Salgado Torres, Group Sales and Service of Puerto Rico, Inc. ................. 95–0958 02/06/95

Molex Incorporated, Mod-Tap W Corp., Mod-Tap W Corp. ....................................................................................... 95–0886 02/07/95

Alma Energy Corp., Unocal Corporation, Union Oil Company of California .............................................................. 95–0932 02/07/95

The Horne Family Voting Trust, Anderson Family Trust, Anderson-Barrows Metals Corporation ............................ 95–0943 02/07/95

Pharmacia AB, Ms. Jacqueline Hoefer, Hoefer Scientific Instruments ....................................................................... 95–0756 02/09/95

Mallinckrodt Group Inc., The Procter & Gamble Company, J. T. Baker Inc. ............................................................. 95–0737 02/10/95

Coats Viyella Plc, BACE Manufacturing, Inc., BACE Manufacturing, Inc. ................................................................. 95–0918 02/10/95

Ronald O. Perelman, Abex Inc., Abex Inc. ................................................................................................................. 95–0929 02/10/95

The News Corporation Limited, SCS Communications, Inc., Westview Press, Inc. .................................................. 95–0944 02/10/95

Ashland Oil, Inc., Mr. Ira L. Morris and Mrs. Betty Sue Morris, Waco Oil & Gas Co., Inc. ....................................... 95–0949 02/10/95

Vincent J. Ryan, James F. Knott, National Business Archives, Inc. .......................................................................... 95–0955 02/10/95

VIAG AG, AmeriQuest Technologies, Inc., AmeriQuest Technologies, Inc. .............................................................. 95–0956 02/10/95

Beverly Enterprises, Inc., Pharmacy Management Services, Inc., Pharmacy Management Services, Inc. .............. 95–0960 02/10/95

Pennzoil Company, Limited Liability Company, Limited Liability Company ............................................................... 95–0961 02/10/95

The Brooklyn Union Gas Company, Limited Liability Company, Limited Liability Company ..................................... 95–0962 02/10/95

Phillips-Van Heusen Corporation, Crystal Brands, Inc. (Debtor-In-Possession), Crystal Brands, Inc. (Debtor-InPossession) ............................................................................................................................................................. 95–0963 02/10/95

Precision Castparts Corp., Columbus II Limited Partnership, Quamco, Inc. .............................................................. 95–0970 02/10/95

William Herbert Hunt Trust Estate, Texaco Inc., Texaco Exploration and Production Inc. ........................................ 95–0978 02/10/95

National Gaming Corp., Part-A-Dice Gaming Corporation, Par-A-Dice Gaming Corporation .................................... 95–0980 02/10/95

Sonat Inc., Hardy Oil & Gas PLC (a Britishcompany), Hardy Holdings, Inc. ............................................................. 95–0993 02/10/95

FOR FURTHER INFORMATION CONTACT:

Sandra M. Peay or Renee A. Horton,

Contact Representatives, Federal Trade

Commission, Premerger Notification

Office, Bureau of Competition, Room

303, Washington, D.C. 20580, (202) 326–

3100.

By direction of the Commission.

Donald S. Clark,

Secretary.

[FR Doc. 95–4396 Filed 2–22–95; 8:45 am]

BILLING CODE 6750–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

Availability of Draft U.S. Public Health

Service Recommendations for HIV

Counseling and Testing for Pregnant

Women

AGENCY: Centers for Disease Control and

Prevention (CDC), Public Health Service

(PHS), Department of Health and

Human Services.

ACTION: Notice of availability and

request for comments.

SUMMARY: This notice announces the

availability for review and comment of

a draft document entitled ‘‘U.S. Public

Health Service Recommendations for

HIV Counseling and Testing for

Pregnant Women.’’ The document was

prepared by CDC staff in collaboration

with other internal PHS and external

consultants.

DATES: To ensure consideration, written

comments on this draft document must

be received on or before April 10, 1995.

ADDRESSES: Requests for copies of the

draft recommendations must be

submitted to the CDC National AIDS

Clearinghouse, P.O. Box 6003,

Rockville, MD 20849–6003, telephone

(800) 458–5231. Written comments on

the draft document should be sent by

mail or facsimile to the Technical

Information Activity, Division of HIV/

AIDS, National Center for Infectious

Diseases, Centers for Disease Control

and Prevention, Mailstop E–49, 1600

Clifton Road, NE., Atlanta, GA 30333,

facsimile (404) 639–2007, for receipt by

April 10, 1995.

FOR FURTHER INFORMATION CONTACT:

Technical Information Activity,

Division of HIV/AIDS, National Center

for Infectious Diseases, Centers for

Disease Control and Prevention,

Mailstop E–49, Atlanta, GA 30333.

SUPPLEMENTARY INFORMATION: In

February 1994, the National Institutes of

Health announced interim results from

AIDS Clinical Trial Group (ACTG)

protocol 076 indicating that zidovudine

(ZDV) therapy administered to a select

group of HIV-infected pregnant women

and their newborns reduced the risk of

perinatal HIV transmission by

approximately two thirds. In April 1994,

provisional recommendations for the

use of ZDV therapy in HIV-infected

pregnant women and their newborns

were published. In June 1994,

representatives from Federal and

nonfederal health agencies and other

organizations attended a meeting in

Bethesda, Maryland, to discuss

development of U.S. Public Health

Service recommendations to prevent

perinatal HIV transmission and the

implications of those recommendations

for HIV treatment, counseling, and HIV

testing. In August 1994, the U.S. Public

Health Service published

recommendations for ZDV therapy to

reduce the risk of perinatal transmission

of HIV (also available from the CDC